Jeffrey Buchsbaum

Dr. Jeffrey Buchsbaum

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in Medical Physics
Verified
Journal Article
Open access
PTPaige A. Taylor
Paige A. Taylor
JMJean M. Moran
Jean M. Moran
DJDavid A. Jaffray
David A. Jaffray
JBJeffrey Buchsbaum
Jeffrey Buchsbaum
While FLASH radiation therapy is inspiring enthusiasm to transform the field, it is neither new nor well understood with respect to the radiobiological mechanisms. As FLASH clinical trials are designed, it will be important to ensure we can deliver dose consistently and safely to every patient. Much like hyperthermia and proton therapy, FLASH is a promising new technology that will be complex to implement in the clinic and similarly will require customized credentialing for multi‐institutional clinical trials. There is no doubt that FLASH seems promising, but many technologies that we take for granted in conventional radiation oncology, such as rigorous dosimetry, 3D treatment planning, volumetric image guidance, or motion management, may play a major role in defining how to use, or whether to use, FLASH radiotherapy. Given the extended time frame for patients to experience late effects, we recommend moving deliberately but cautiously forward toward clinical trials. In this paper, we review the state of quality assurance and safety systems in FLASH, identify critical pre‐clinical data points that need to be defined, and suggest how lessons learned from previous technological advancements will help us close the gaps and build a successful path to evidence‐driven FLASH implementation.

1 July 2019 in Practical Radiation Oncology
Verified
Journal Article
Closed access
AYAdam D. Yock
Adam D. Yock
RMRadhe Mohan
Radhe Mohan
SFStella Flampouri
Stella Flampouri
WBWalter Bosch
Walter Bosch
PTPaige A. Taylor
Paige A. Taylor
JBJeffrey Buchsbaum
Jeffrey Buchsbaum

1 November 2017 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
SKStephen F. Kralik
Stephen F. Kralik
GWGordon A. Watson
Gordon A. Watson
CSChie-Schin Shih
Chie-Schin Shih
CHChang Y. Ho
Chang Y. Ho
WFWhitney Finke
Whitney Finke
JBJeffrey Buchsbaum
Jeffrey Buchsbaum

26 July 2024 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
HPHarald Paganetti
Harald Paganetti
CSCharles B. Simone
Charles B. Simone
WBWalter R. Bosch
Walter R. Bosch
DHDaphne Haas-Kogan
Daphne Haas-Kogan
DKDavid G. Kirsch
David G. Kirsch
JBJeffrey Buchsbaum
Jeffrey Buchsbaum

30 April 2018 in Cancer Research
Verified
Journal Article
Open access
PDF file
MAMansoor M. Ahmed
Mansoor M. Ahmed
CCC. Norman Coleman
C. Norman Coleman
MMMarc Mendonca
Marc Mendonca
SBSoren Bentzen
Soren Bentzen
BVBhadrasain Vikram
Bhadrasain Vikram
JMJames Mitchell
James Mitchell
The ability to physically target radiotherapy using image-guidance is continually improving with photons and particle therapy that include protons and heavier ions such as carbon. The unit of dose deposited is the gray (Gy); however, particle therapies produce different patterns of ionizations, and

2 February 2026 in The Lancet Oncology
Verified
Journal Article
Closed access
KPKelly C Paradis
Kelly C Paradis
AAAne L Appelt
Ane L Appelt
SBSoren M Bentzen
Soren M Bentzen
NCNick Chng
Nick Chng
ECElizabeth L Covington
Elizabeth L Covington
JBJeffrey Buchsbaum
Jeffrey Buchsbaum